OpenVigil FDA - Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications

Pharmacovigilance contributes to health care. However, direct access to the underlying data for academic institutions and individual physicians or pharmacists is intricate, and easily employable analysis modes for everyday clinical situations are missing. This underlines the need for a tool to bring...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2016-06, Vol.11 (6), p.e0157753-e0157753
Hauptverfasser:	Böhm, Ruwen, von Hehn, Leocadie, Herdegen, Thomas, Klein, Hans-Joachim, Bruhn, Oliver, Petri, Holger, Höcker, Jan
Format:	Artikel
Sprache:	eng
Schlagworte:	Access to Information Adverse Drug Reaction Reporting Systems Affect - drug effects Algorithms Antiemetics - adverse effects Archives & records Big Data Biology and Life Sciences Computer and Information Sciences Contingency tables Data Mining Drug Interactions Drug Therapy, Combination Drugs Epilepsy - drug therapy Health care Humans Incident reporting (Medical care) Information retrieval Inspection Laws, regulations and rules Licenses Medical personnel Medicine and Health Sciences Neuralgia - drug therapy Ontology Pain Pharmacology Pharmacovigilance Physical Sciences Physicians Prescription Drugs - adverse effects Programming languages Protein Kinase Inhibitors - pharmacology Protein Kinase Inhibitors - therapeutic use Queries Regulatory agencies Research and Analysis Methods Risk Factors Social Sciences Therapeutic applications United States United States Food and Drug Administration User interface
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!